Efficacy and safety of teicoplanin in CDAD

Trial Identifier: LPS16229
Sponsor: sanofi
Start Date: May 2020
Primary Completion Date: January 2021
Study Completion Date: March 2021
Condition: Infections - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
China China, China